Caroline Wilson

University of Bristol

Papers

1

Total Citations

55

H-Index

1

About

Caroline Wilson is a leading urological surgeon and clinical academic whose research focuses on advancing surgical treatments for advanced prostate cancer. Her most impactful work centers on the role of radical prostatectomy in men with oligo-metastatic disease, challenging the long-held paradigm that surgery is ineffective once cancer has spread. Wilson is the lead author of the landmark TRoMbone trial (2021, 55 citations), the first prospective, randomized feasibility study to test whether radical prostatectomy plus pelvic lymphadenectomy can be safely added to standard systemic therapy in men with newly diagnosed oligo-metastatic prostate cancer. This pioneering work demonstrated that randomization to surgery is not only feasible but safe, laying the essential groundwork for larger, definitive trials that could fundamentally change treatment guidelines. By rigorously testing the boundaries of surgical intervention in metastatic disease, Wilson has opened a new frontier in uro-oncology, offering renewed hope for patients with limited metastatic spread. Her contributions are shaping a more aggressive, multi-modal approach to a disease traditionally managed with systemic therapy alone.

Research Focus

Key Achievements

1
H-Index
1
Papers
55
Total Citations
55
Avg Citations/Paper
🏆 Most Cited Paper
Feasibility and safety of radical prostatectomy for oligo‐metastatic prostate cancer: the Testing Radical prostatectomy in men with prostate cancer and oligo‐Metastases to the bone (TRoMbone) trial
55 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 19
🏛 Institutions: University of Bristol

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago